Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Anaplastic Oligodendroglioma · Astrocytoma, IDH-Mutant, Grade 3 · Astrocytoma, IDH-Mutant, Grade 4 · Diffuse Astrocytoma · Glioblastoma, IDH-Wildtype · Malignant Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic in Rochester, Rochester, Minnesota, United States
Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
Contact: Principal Investigator (Terence C. Burns, MD, PhD)

Study leads

Terence C. Burns, MD, PhD
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Implantable Microdevice In Primary Brain Tumors

Grade II Glioma · Grade III Glioma · Grade IV Glioma

Abroad (travel likely)RecruitingEARLY_PHASE1

Boston, United States

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Anaplastic Astrocytoma, IDH-Wildtype · Anaplastic Oligoastrocytoma · Anaplastic Oligodendroglioma

Abroad (travel likely)RecruitingPHASE2

Houston, United States

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Neoplasms, Brain · Glioblastoma Multiforme · Glioblastoma of Cerebellum

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · St Louis, United States

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Central Nervous System Neoplasms · Glioblastoma · Gliosarcoma, Adult

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States